Iron metabolism imbalance at the time of listing increases overall and infectious mortality after liver transplantation

Table 1 Baseline patient characteristics

Variable	n = 553
Age, yr	55 (49-60.5)
Sex male/female	414 (74.9)/139 (25.1)
BMI, kg/m²	26.2 (23.3-29.7)
Iron metabolism
Serum iron, µmol/L	21.9 (1.6; 57.9)
Transferrin, g/L	2.10 (1.5-2.5)
Transferrin saturation, %	43.6 (25.1-74.5)
Transferrin saturation > 75%	136 (24.6)
Serum ferritin, µg/L	241 (75.5-593.5)
< 100	168 (30.4)
100-400	185 (33.5)
> 400	200 (36.2)
Cirrhosis etiology
Alcohol	340 (61.5)
Viral hepatitis C	89 (16.1)
Viral hepatitis B	18 (3.3)
Primary sclerosing cholangitis	20 (3.6)
Primary biliary cholangitis	12 (2.2)
Auto-immune	10 (1.8)
Hemochromatosis	17 (3.0)
Others	47 (8.4)
Hepatocellular carcinoma	214 (38.7)
Child pugh score
A	206 (39.1)
B	158 (30.0)
C	163 (31.0)
MELD	15.1 (10.6-20.7)
Donor age, yr	49 (37-62)
Donor BMI, kg/m2	24.3 (21.9-27.6)
Cold ischemia, minutes	592 (446-723)
Perioperative transfusion
Packed red cell, n	5 (2-8)
Fresh frozen plasma, n	6 (2-9)
ICU length of stay, d	4 (3-7)

For categorical variables, data are given as n (%). For continuous variables, data are given as median (range). BMI: Body mass index; ICU: Intensive care unit; MELD: Model of End-Stage Liver Disease.